Federation Bio Revenue and Competitors
Estimated Revenue & Valuation
- Federation Bio's estimated annual revenue is currently $4.3M per year.
- Federation Bio's estimated revenue per employee is $77,500
- Federation Bio's total funding is $50M.
Employee Data
- Federation Bio has 55 Employees.
- Federation Bio grew their employee count by 25% last year.
Federation Bio's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP Technical Operations | Reveal Email/Phone |
4 | Director, Information Technology at Federation Bio | Reveal Email/Phone |
5 | Director Manufacturing Operations and Formulation Development | Reveal Email/Phone |
6 | Chief Legal Officer, Acting COO, & Corporate Secretary | Reveal Email/Phone |
7 | Director Regulatory Affairs | Reveal Email/Phone |
8 | Associate Director Process and Analytical Development | Reveal Email/Phone |
9 | Associate Director Translational Research | Reveal Email/Phone |
10 | People and Culture Lead | Reveal Email/Phone |
Federation Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Federation Bio?
Federation Bio is pioneering new platforms that target diseases in which the human microbiome can play a curative role. The company’s microbial approach leverages naturally occurring bacteria along with a diverse community of supportive bacteria to drive engraftment and durable therapeutic responses. This approach has potential in a diverse set of human conditions ranging from metabolic disorders and cholestatic diseases to cancer and autoimmune conditions. Federation Bio’s lead program is in secondary hyperoxaluria, a serious renal condition that affects more than 200,000 Americans and for which there are currently no approved therapies. Additional information can be found at www.federation.bio
keywords:N/A$50M
Total Funding
55
Number of Employees
$4.3M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Federation Bio News
Prior to Federation Bio, she spent over a decade at 23andMe where, as Vice President of Business Development, she was instrumental in...
Federation Bio — a microbial therapeutics company targeting diseases in which the human microbiome can play a curative role — announced that it has raised $50 million in a Series A round of funding Federation Bio — a microbial therapeutics company targeting diseases in which the human microbiom ...
Federation Bio, a South San Francisco, CA-based microbial therapeutics company targeting diseases in which the human microbiome can play a curative role, closed a $50m Series A financing. Horizons Ventures led the Series A financing, joined by existing investors Venrock and Altitude, and additi ...
SOUTH SAN FRANCISCO, Calif., Oct. 6, 2020 /PRNewswire/ -- Federation Bio, a microbial therapeutics company targeting diseases in which the human microbiome can play a curative role, today announced that it has closed a $50 million Series A financing and expanded its leadership team. Federation ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.2M | 55 | -20% | N/A |
#2 | $9.8M | 55 | -13% | $98.3M |
#3 | $12.4M | 55 | 31% | N/A |
#4 | $8.1M | 55 | -24% | $77.5M |
#5 | $6.7M | 55 | -4% | $18.5M |